| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702201 | Practical Radiation Oncology | 2016 | 30 Pages |
Abstract
Consistent with national guideline recommendations, our analysis supports preferred status for RT in CS IIA. In addition, these data also support use of RT for CS IIB. CS, treatment year, primary pathologic tumor stage, insurance, and facility type were associated with type of postoperative therapy. Longer follow-up to account for potential late effects of treatment is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jonathan J. DO, Chun Chieh PhD MBA, Phillip J. MD, Christopher L. MD, Clair MD, Helmneh MD MPH, Ahmedin DVM PhD, Jason A. MD DPhil,